News & Articles

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

Watch this webinar on demand to learn about the host immune response to COVID-19

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions

Harvey J. Alter, Michael Houghton, and Charles M. Rice are joint winners of 2020 Nobel Prize for medicine

Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology

Affimer-based research assay launched alongside performance data published by Bruker

Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field

Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back

Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic

The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay